Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $53.05 million. The enterprise value is $53.08 million.

Market Cap	53.05M
Enterprise Value	53.08M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ELTX has 10.76 million shares outstanding. The number of shares has increased by 30.44% in one year.

Current Share Class	10.76M
Shares Outstanding	10.76M
Shares Change (YoY)	+30.44%
Shares Change (QoQ)	+20.36%
Owned by Insiders (%)	19.80%
Owned by Institutions (%)	9.00%
Float	8.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.40

Current Ratio	3.40
Quick Ratio	2.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-183.42

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-73.70%
Return on Capital (ROIC)	-192.46%
Revenue Per Employee	n/a
Profits Per Employee	-$1.46M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.01%
50-Day Moving Average	4.83
200-Day Moving Average	5.88
Relative Strength Index (RSI)	50.13
Average Volume (20 Days)	28,644

Short Selling Information

The latest short interest is 42,962, so 0.40% of the outstanding shares have been sold short.

Short Interest	42,962
Short Previous Month	39,918
Short % of Shares Out	0.40%
Short % of Float	0.51%
Short Ratio (days to cover)	2.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.90M
Pretax Income	-38.99M
Net Income	-46.84M
EBITDA	-40.59M
EBIT	-40.90M
Earnings Per Share (EPS)	-$4.29

Full Income Statement

Balance Sheet

The company has $26.02 million in cash and $26.05 million in debt, giving a net cash position of -$34,000 or -$0.00 per share.

Cash & Cash Equivalents	26.02M
Total Debt	26.05M
Net Cash	-34,000
Net Cash Per Share	-$0.00
Equity (Book Value)	-18.99M
Book Value Per Share	-1.76
Working Capital	21.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.22 million and capital expenditures -$42,000, giving a free cash flow of -$38.26 million.

Operating Cash Flow	-38.22M
Capital Expenditures	-42,000
Free Cash Flow	-38.26M
FCF Per Share	-$3.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.44%
Shareholder Yield	-30.44%
Earnings Yield	-88.30%
FCF Yield	-72.13%

Analyst Forecast

The average price target for ELTX is $9.50, which is 92.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	92.70%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2